CA3067321C - Utilisation d’acétyle-leucine pour prévenir et/ou traiter la migraine - Google Patents

Utilisation d’acétyle-leucine pour prévenir et/ou traiter la migraine

Info

Publication number
CA3067321C
CA3067321C CA3067321A CA3067321A CA3067321C CA 3067321 C CA3067321 C CA 3067321C CA 3067321 A CA3067321 A CA 3067321A CA 3067321 A CA3067321 A CA 3067321A CA 3067321 C CA3067321 C CA 3067321C
Authority
CA
Canada
Prior art keywords
leucine
acetyl
pharmaceutically acceptable
acceptable salt
migraine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3067321A
Other languages
English (en)
Other versions
CA3067321A1 (fr
Inventor
Michael Strupp
Mallory Factor
Original Assignee
Intrabio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1709459.0A external-priority patent/GB201709459D0/en
Application filed by Intrabio Ltd filed Critical Intrabio Ltd
Publication of CA3067321A1 publication Critical patent/CA3067321A1/fr
Application granted granted Critical
Publication of CA3067321C publication Critical patent/CA3067321C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

Un premier aspect de l’invention concerne la leucine, l’acétyle-leucine, ou un sel pharmaceutiquement acceptable de celles-ci, destinés à être utilisés dans le traitement ou la prévention d’une migraine ou d’un ou de plusieurs symptômes associés à celle-ci. Un deuxième aspect de l’invention concerne un procédé de traitement ou de prévention d’une migraine, d’un ou de plusieurs symptômes associés à celle-ci, chez un sujet, ledit procédé comprenant l’administration au sujet d’une quantité thérapeutiquement ou prophylactiquement efficace de la leucine, de l’acétyle-leucine ou d’un sel pharmaceutiquement acceptable de celles-ci.
CA3067321A 2017-06-14 2018-06-25 Utilisation d’acétyle-leucine pour prévenir et/ou traiter la migraine Active CA3067321C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1709459.0 2017-06-14
GBGB1709459.0A GB201709459D0 (en) 2017-06-14 2017-06-14 Treatment for migraine
PCT/IB2018/054676 WO2018229738A1 (fr) 2017-06-14 2018-06-25 Traitement pour de la migraine

Publications (2)

Publication Number Publication Date
CA3067321A1 CA3067321A1 (fr) 2018-12-20
CA3067321C true CA3067321C (fr) 2025-07-08

Family

ID=

Similar Documents

Publication Publication Date Title
KR20120101456A (ko) 중추 매개의 오심 및 구토를 치료하기 위한 조성물 및 방법
JP2018507874A (ja) 過剰な体脂肪の治療処置または美容処置のためのｎｋ−３受容体拮抗薬
IL293266A (en) Acetyl-leucine or its acceptable pharmacy salt for improved mobility and cognitive function
JP2007506801A (ja) モダフィニルおよび他の薬剤を含んでなる製薬学的組成物
US11471434B2 (en) Treatment for migraine
US10500170B2 (en) Composition and method for treating neurological disease
Leppert et al. Recommendations for assessment and management of pain in cancer patients
US20150335624A1 (en) Compositions and methods for using huperzine and analogs thereof
CA3067321C (fr) Utilisation d’acétyle-leucine pour prévenir et/ou traiter la migraine
ES2983441T3 (es) Acetil-leucina para su uso en el tratamiento de síndrome de las piernas inquietas
RU2772278C2 (ru) Лечение мигрени
WO2001000196A2 (fr) Mirtazapine destinee a la prise de poids dans les maladies cachectisantes
HK40023292B (en) Treatment of migraine with acetyl-leucine
HK40023292A (en) Treatment of migraine with acetyl-leucine
KR20070083903A (ko) 경구 효과적인 칸나비노이드 유사체
ES2977185T3 (es) Administración intranasal de ketamina a pacientes con cefalea en racimos
BR112019026660B1 (pt) Uso de acetil-leucina ou seu sal para preparação demedicamento para tratar ou prevenir enxaqueca ou sintomas associados
US20140148465A1 (en) Compositions and Methods to Improve Treatment of Medical Conditions Using D-Cycloserine
AU2012391533B2 (en) Combination for the prophylaxis and treatment of behavioural, mental and cognitive disorders
US4711891A (en) Use of terguride as a geriatric agent
US20240293435A1 (en) Methods and Compositions for Treating Human Disorders Using D-Cycloserine and a Psychedelic Agent
JP2024505283A (ja) 遂行機能障害の処置のための併用療法
EA049139B1 (ru) Лечение симптомов, вызванных менструальным циклом
CN114080221A (zh) 用于减轻疼痛的布洛芬与曲马多的组合